Nalaganje...
The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC)
A biosimilar is a biologic product that is similar to a reference biopharmaceutical product, the manufacturing process of which hinders the ability to identically replicate the structure of the original product, and therefore, it cannot be described as an absolute equivalent of the original medicati...
Shranjeno v:
| izdano v: | Braz J Med Biol Res |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Associação Brasileira de Divulgação Científica
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5769764/ https://ncbi.nlm.nih.gov/pubmed/29340530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1414-431X20177214 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|